世界のIBS-C治療薬市場予測2021-2027:リナクロチド、ルビプロストン、浸透圧性下剤、覚醒剤下剤、その他

Market Monitor Globalが発行した調査報告書(MMG21DC17720)
◆英語タイトル:IBS-C Drugs Market - Global Outlook and Forecast 2021-2027
◆商品コード:MMG21DC17720
◆発行会社(リサーチ会社):Market Monitor Global
◆発行日:2021年12月
◆ページ数:111
◆レポート形式:英語 / PDF
◆納品方法:Eメール(受注後2-3営業日)
◆調査対象地域:グローバル、北米、アメリカ、ヨーロッパ、アジア、日本、中国、東南アジア、インド、南米、中東・アフリカなど
◆産業分野:医薬品
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD3,250 ⇒換算¥455,000見積依頼/購入/質問フォーム
Multi User(20名様閲覧用)USD4,225 ⇒換算¥591,500見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarket Monitor Global社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。Market Monitor Global社の概要及び新刊レポートはこちらでご確認いただけます。

Market Monitor Global社が発行した本調査レポートは、世界のIBS-C治療薬市場について調査し取りまとめました。IBS-C治療薬の世界市場規模(2016年-2027年)、市場予測、企業別市場シェア、種類別分析(リナクロチド、ルビプロストン、浸透圧性下剤、覚醒剤下剤、その他)、用途別分析(病院薬局、小売薬局、オンライン薬局)、地域別分析(北米、アメリカ、カナダ、メキシコ、ヨーロッパ、ドイツ、フランス、イギリス、アジア、中国、日本、韓国、東南アジア、インド、南米、ブラジル、中東、アフリカなど)、関連メーカーの概要、市場動向・機会・成長・阻害要因、サプライチェーンなどの情報をお届けいたします。
・世界のIBS-C治療薬市場規模2021年vs2027年
・世界のIBS-C治療薬市場:売上予測2016年-2027年
・主要企業別のIBS-C治療薬売上・市場シェア・価格
・IBS-C治療薬の種類別市場規模:リナクロチド、ルビプロストン、浸透圧性下剤、覚醒剤下剤、その他
・IBS-C治療薬の用途別市場規模:病院薬局、小売薬局、オンライン薬局
・地域別市場規模
・IBS-C治療薬の北米市場:アメリカ市場、カナダ市場、メキシコ市場
・IBS-C治療薬のヨーロッパ市場:ドイツ市場、フランス市場、イギリス市場など
・IBS-C治療薬のアジア市場:中国市場、日本市場、韓国市場、東南アジア市場など
・IBS-C治療薬の南米市場:ブラジル市場、アルゼンチン市場など
・IBS-C治療薬の中東・アフリカ市場:トルコ市場、サウジアラビア市場、UAE市場など
・主要メーカー及びブランド概要:Catalent Pharmaceuticals Solutions、Nestle、Abbott Laboratories、Synergy Pharmaceuticals、Sucampo Pharmaceuticals、Novartis Pharma Ag、Astellas Pharmaceuticals、Ardelyx, Inc、Synthetic Biologics, Inc、Teva Pharmaceutical Industries、Bama-Geve, SLU、Ferring BV、Ironwood Pharmaceuticals, Inc、Salix Pharmaceuticals Ltd、Norgine B.V、Prometheus Laboratories Inc、Actavis Nordic A/S、Albireo Pharma Inc、Yuhan Corp、Astrazeneca Plc、The Menarini Group、Ono Pharmaceutical Co., Ltd
・世界のIBS-C治療薬の生産能力2016年-2027年
・市場動向・機会・成長・阻害要因分析
・IBS-C治療薬のサプライチェーン分析
・調査の結論
【レポートの概要】

This report contains market size and forecasts of IBS-C Drugs in global, including the following market information:
Global IBS-C Drugs Market Revenue, 2016-2021, 2022-2027, ($ millions)
Global IBS-C Drugs Market Sales, 2016-2021, 2022-2027, (K Pcs)
Global top five IBS-C Drugs companies in 2020 (%)
The global IBS-C Drugs market was valued at xx million in 2020 and is projected to reach US$ xx million by 2027, at a CAGR of xx% during the forecast period.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the IBS-C Drugs manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global IBS-C Drugs Market, By Type, 2016-2021, 2022-2027 ($ Millions) & (K Pcs)
Global IBS-C Drugs Market Segment Percentages, By Type, 2020 (%)
Linaclotide
Lubiprostone
Osmotic Laxatives
Stimulant Laxatives
Others

Global IBS-C Drugs Market, By Application, 2016-2021, 2022-2027 ($ Millions) & (K Pcs)
Global IBS-C Drugs Market Segment Percentages, By Application, 2020 (%)
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies

Global IBS-C Drugs Market, By Region and Country, 2016-2021, 2022-2027 ($ Millions) & (K Pcs)
Global IBS-C Drugs Market Segment Percentages, By Region and Country, 2020 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa

Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies IBS-C Drugs revenues in global market, 2016-2021 (Estimated), ($ millions)
Key companies IBS-C Drugs revenues share in global market, 2020 (%)
Key companies IBS-C Drugs sales in global market, 2016-2021 (Estimated), (K Pcs)
Key companies IBS-C Drugs sales share in global market, 2020 (%)
Further, the report presents profiles of competitors in the market, key players include:
Catalent Pharmaceuticals Solutions
Nestle
Abbott Laboratories
Synergy Pharmaceuticals
Sucampo Pharmaceuticals
Novartis Pharma Ag
Astellas Pharmaceuticals
Ardelyx, Inc
Synthetic Biologics, Inc
Teva Pharmaceutical Industries
Bama-Geve, SLU
Ferring BV
Ironwood Pharmaceuticals, Inc
Salix Pharmaceuticals Ltd
Norgine B.V
Prometheus Laboratories Inc
Actavis Nordic A/S
Albireo Pharma Inc
Yuhan Corp
Astrazeneca Plc
The Menarini Group
Ono Pharmaceutical Co., Ltd

【レポートの目次】

1 Introduction to Research & Analysis Reports
1.1 IBS-C Drugs Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global IBS-C Drugs Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global IBS-C Drugs Overall Market Size
2.1 Global IBS-C Drugs Market Size: 2021 VS 2027
2.2 Global IBS-C Drugs Revenue, Prospects & Forecasts: 2016-2027
2.3 Global IBS-C Drugs Sales (Consumption): 2016-2027
3 Company Landscape
3.1 Top IBS-C Drugs Players in Global Market
3.2 Top Global IBS-C Drugs Companies Ranked by Revenue
3.3 Global IBS-C Drugs Revenue by Companies
3.4 Global IBS-C Drugs Sales by Companies
3.5 Global IBS-C Drugs Price by Manufacturer (2016-2021)
3.6 Top 3 and Top 5 IBS-C Drugs Companies in Global Market, by Revenue in 2020
3.7 Global Manufacturers IBS-C Drugs Product Type
3.8 Tier 1, Tier 2 and Tier 3 IBS-C Drugs Players in Global Market
3.8.1 List of Global Tier 1 IBS-C Drugs Companies
3.8.2 List of Global Tier 2 and Tier 3 IBS-C Drugs Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type – Global IBS-C Drugs Market Size Markets, 2021 & 2027
4.1.2 Linaclotide
4.1.3 Lubiprostone
4.1.4 Osmotic Laxatives
4.1.5 Stimulant Laxatives
4.1.6 Others
4.2 By Type – Global IBS-C Drugs Revenue & Forecasts
4.2.1 By Type – Global IBS-C Drugs Revenue, 2016-2021
4.2.2 By Type – Global IBS-C Drugs Revenue, 2022-2027
4.2.3 By Type – Global IBS-C Drugs Revenue Market Share, 2016-2027
4.3 By Type – Global IBS-C Drugs Sales & Forecasts
4.3.1 By Type – Global IBS-C Drugs Sales, 2016-2021
4.3.2 By Type – Global IBS-C Drugs Sales, 2022-2027
4.3.3 By Type – Global IBS-C Drugs Sales Market Share, 2016-2027
4.4 By Type – Global IBS-C Drugs Price (Manufacturers Selling Prices), 2016-2027
5 Sights by Application
5.1 Overview
5.1.1 By Application – Global IBS-C Drugs Market Size, 2021 & 2027
5.1.2 Hospital Pharmacies
5.1.3 Retail Pharmacies
5.1.4 Online Pharmacies
5.2 By Application – Global IBS-C Drugs Revenue & Forecasts
5.2.1 By Application – Global IBS-C Drugs Revenue, 2016-2021
5.2.2 By Application – Global IBS-C Drugs Revenue, 2022-2027
5.2.3 By Application – Global IBS-C Drugs Revenue Market Share, 2016-2027
5.3 By Application – Global IBS-C Drugs Sales & Forecasts
5.3.1 By Application – Global IBS-C Drugs Sales, 2016-2021
5.3.2 By Application – Global IBS-C Drugs Sales, 2022-2027
5.3.3 By Application – Global IBS-C Drugs Sales Market Share, 2016-2027
5.4 By Application – Global IBS-C Drugs Price (Manufacturers Selling Prices), 2016-2027
6 Sights by Region
6.1 By Region – Global IBS-C Drugs Market Size, 2021 & 2027
6.2 By Region – Global IBS-C Drugs Revenue & Forecasts
6.2.1 By Region – Global IBS-C Drugs Revenue, 2016-2021
6.2.2 By Region – Global IBS-C Drugs Revenue, 2022-2027
6.2.3 By Region – Global IBS-C Drugs Revenue Market Share, 2016-2027
6.3 By Region – Global IBS-C Drugs Sales & Forecasts
6.3.1 By Region – Global IBS-C Drugs Sales, 2016-2021
6.3.2 By Region – Global IBS-C Drugs Sales, 2022-2027
6.3.3 By Region – Global IBS-C Drugs Sales Market Share, 2016-2027
6.4 North America
6.4.1 By Country – North America IBS-C Drugs Revenue, 2016-2027
6.4.2 By Country – North America IBS-C Drugs Sales, 2016-2027
6.4.3 US IBS-C Drugs Market Size, 2016-2027
6.4.4 Canada IBS-C Drugs Market Size, 2016-2027
6.4.5 Mexico IBS-C Drugs Market Size, 2016-2027
6.5 Europe
6.5.1 By Country – Europe IBS-C Drugs Revenue, 2016-2027
6.5.2 By Country – Europe IBS-C Drugs Sales, 2016-2027
6.5.3 Germany IBS-C Drugs Market Size, 2016-2027
6.5.4 France IBS-C Drugs Market Size, 2016-2027
6.5.5 U.K. IBS-C Drugs Market Size, 2016-2027
6.5.6 Italy IBS-C Drugs Market Size, 2016-2027
6.5.7 Russia IBS-C Drugs Market Size, 2016-2027
6.5.8 Nordic Countries IBS-C Drugs Market Size, 2016-2027
6.5.9 Benelux IBS-C Drugs Market Size, 2016-2027
6.6 Asia
6.6.1 By Region – Asia IBS-C Drugs Revenue, 2016-2027
6.6.2 By Region – Asia IBS-C Drugs Sales, 2016-2027
6.6.3 China IBS-C Drugs Market Size, 2016-2027
6.6.4 Japan IBS-C Drugs Market Size, 2016-2027
6.6.5 South Korea IBS-C Drugs Market Size, 2016-2027
6.6.6 Southeast Asia IBS-C Drugs Market Size, 2016-2027
6.6.7 India IBS-C Drugs Market Size, 2016-2027
6.7 South America
6.7.1 By Country – South America IBS-C Drugs Revenue, 2016-2027
6.7.2 By Country – South America IBS-C Drugs Sales, 2016-2027
6.7.3 Brazil IBS-C Drugs Market Size, 2016-2027
6.7.4 Argentina IBS-C Drugs Market Size, 2016-2027
6.8 Middle East & Africa
6.8.1 By Country – Middle East & Africa IBS-C Drugs Revenue, 2016-2027
6.8.2 By Country – Middle East & Africa IBS-C Drugs Sales, 2016-2027
6.8.3 Turkey IBS-C Drugs Market Size, 2016-2027
6.8.4 Israel IBS-C Drugs Market Size, 2016-2027
6.8.5 Saudi Arabia IBS-C Drugs Market Size, 2016-2027
6.8.6 UAE IBS-C Drugs Market Size, 2016-2027
7 Manufacturers & Brands Profiles
7.1 Catalent Pharmaceuticals Solutions
7.1.1 Catalent Pharmaceuticals Solutions Corporate Summary
7.1.2 Catalent Pharmaceuticals Solutions Business Overview
7.1.3 Catalent Pharmaceuticals Solutions IBS-C Drugs Major Product Offerings
7.1.4 Catalent Pharmaceuticals Solutions IBS-C Drugs Sales and Revenue in Global (2016-2021)
7.1.5 Catalent Pharmaceuticals Solutions Key News
7.2 Nestle
7.2.1 Nestle Corporate Summary
7.2.2 Nestle Business Overview
7.2.3 Nestle IBS-C Drugs Major Product Offerings
7.2.4 Nestle IBS-C Drugs Sales and Revenue in Global (2016-2021)
7.2.5 Nestle Key News
7.3 Abbott Laboratories
7.3.1 Abbott Laboratories Corporate Summary
7.3.2 Abbott Laboratories Business Overview
7.3.3 Abbott Laboratories IBS-C Drugs Major Product Offerings
7.3.4 Abbott Laboratories IBS-C Drugs Sales and Revenue in Global (2016-2021)
7.3.5 Abbott Laboratories Key News
7.4 Synergy Pharmaceuticals
7.4.1 Synergy Pharmaceuticals Corporate Summary
7.4.2 Synergy Pharmaceuticals Business Overview
7.4.3 Synergy Pharmaceuticals IBS-C Drugs Major Product Offerings
7.4.4 Synergy Pharmaceuticals IBS-C Drugs Sales and Revenue in Global (2016-2021)
7.4.5 Synergy Pharmaceuticals Key News
7.5 Sucampo Pharmaceuticals
7.5.1 Sucampo Pharmaceuticals Corporate Summary
7.5.2 Sucampo Pharmaceuticals Business Overview
7.5.3 Sucampo Pharmaceuticals IBS-C Drugs Major Product Offerings
7.5.4 Sucampo Pharmaceuticals IBS-C Drugs Sales and Revenue in Global (2016-2021)
7.5.5 Sucampo Pharmaceuticals Key News
7.6 Novartis Pharma Ag
7.6.1 Novartis Pharma Ag Corporate Summary
7.6.2 Novartis Pharma Ag Business Overview
7.6.3 Novartis Pharma Ag IBS-C Drugs Major Product Offerings
7.6.4 Novartis Pharma Ag IBS-C Drugs Sales and Revenue in Global (2016-2021)
7.6.5 Novartis Pharma Ag Key News
7.7 Astellas Pharmaceuticals
7.7.1 Astellas Pharmaceuticals Corporate Summary
7.7.2 Astellas Pharmaceuticals Business Overview
7.7.3 Astellas Pharmaceuticals IBS-C Drugs Major Product Offerings
7.4.4 Astellas Pharmaceuticals IBS-C Drugs Sales and Revenue in Global (2016-2021)
7.7.5 Astellas Pharmaceuticals Key News
7.8 Ardelyx, Inc
7.8.1 Ardelyx, Inc Corporate Summary
7.8.2 Ardelyx, Inc Business Overview
7.8.3 Ardelyx, Inc IBS-C Drugs Major Product Offerings
7.8.4 Ardelyx, Inc IBS-C Drugs Sales and Revenue in Global (2016-2021)
7.8.5 Ardelyx, Inc Key News
7.9 Synthetic Biologics, Inc
7.9.1 Synthetic Biologics, Inc Corporate Summary
7.9.2 Synthetic Biologics, Inc Business Overview
7.9.3 Synthetic Biologics, Inc IBS-C Drugs Major Product Offerings
7.9.4 Synthetic Biologics, Inc IBS-C Drugs Sales and Revenue in Global (2016-2021)
7.9.5 Synthetic Biologics, Inc Key News
7.10 Teva Pharmaceutical Industries
7.10.1 Teva Pharmaceutical Industries Corporate Summary
7.10.2 Teva Pharmaceutical Industries Business Overview
7.10.3 Teva Pharmaceutical Industries IBS-C Drugs Major Product Offerings
7.10.4 Teva Pharmaceutical Industries IBS-C Drugs Sales and Revenue in Global (2016-2021)
7.10.5 Teva Pharmaceutical Industries Key News
7.11 Bama-Geve, SLU
7.11.1 Bama-Geve, SLU Corporate Summary
7.11.2 Bama-Geve, SLU IBS-C Drugs Business Overview
7.11.3 Bama-Geve, SLU IBS-C Drugs Major Product Offerings
7.11.4 Bama-Geve, SLU IBS-C Drugs Sales and Revenue in Global (2016-2021)
7.11.5 Bama-Geve, SLU Key News
7.12 Ferring BV
7.12.1 Ferring BV Corporate Summary
7.12.2 Ferring BV IBS-C Drugs Business Overview
7.12.3 Ferring BV IBS-C Drugs Major Product Offerings
7.12.4 Ferring BV IBS-C Drugs Sales and Revenue in Global (2016-2021)
7.12.5 Ferring BV Key News
7.13 Ironwood Pharmaceuticals, Inc
7.13.1 Ironwood Pharmaceuticals, Inc Corporate Summary
7.13.2 Ironwood Pharmaceuticals, Inc IBS-C Drugs Business Overview
7.13.3 Ironwood Pharmaceuticals, Inc IBS-C Drugs Major Product Offerings
7.13.4 Ironwood Pharmaceuticals, Inc IBS-C Drugs Sales and Revenue in Global (2016-2021)
7.13.5 Ironwood Pharmaceuticals, Inc Key News
7.14 Salix Pharmaceuticals Ltd
7.14.1 Salix Pharmaceuticals Ltd Corporate Summary
7.14.2 Salix Pharmaceuticals Ltd Business Overview
7.14.3 Salix Pharmaceuticals Ltd IBS-C Drugs Major Product Offerings
7.14.4 Salix Pharmaceuticals Ltd IBS-C Drugs Sales and Revenue in Global (2016-2021)
7.14.5 Salix Pharmaceuticals Ltd Key News
7.15 Norgine B.V
7.15.1 Norgine B.V Corporate Summary
7.15.2 Norgine B.V Business Overview
7.15.3 Norgine B.V IBS-C Drugs Major Product Offerings
7.15.4 Norgine B.V IBS-C Drugs Sales and Revenue in Global (2016-2021)
7.15.5 Norgine B.V Key News
7.16 Prometheus Laboratories Inc
7.16.1 Prometheus Laboratories Inc Corporate Summary
7.16.2 Prometheus Laboratories Inc Business Overview
7.16.3 Prometheus Laboratories Inc IBS-C Drugs Major Product Offerings
7.16.4 Prometheus Laboratories Inc IBS-C Drugs Sales and Revenue in Global (2016-2021)
7.16.5 Prometheus Laboratories Inc Key News
7.17 Actavis Nordic A/S
7.17.1 Actavis Nordic A/S Corporate Summary
7.17.2 Actavis Nordic A/S Business Overview
7.17.3 Actavis Nordic A/S IBS-C Drugs Major Product Offerings
7.17.4 Actavis Nordic A/S IBS-C Drugs Sales and Revenue in Global (2016-2021)
7.17.5 Actavis Nordic A/S Key News
7.18 Albireo Pharma Inc
7.18.1 Albireo Pharma Inc Corporate Summary
7.18.2 Albireo Pharma Inc Business Overview
7.18.3 Albireo Pharma Inc IBS-C Drugs Major Product Offerings
7.18.4 Albireo Pharma Inc IBS-C Drugs Sales and Revenue in Global (2016-2021)
7.18.5 Albireo Pharma Inc Key News
7.19 Yuhan Corp
7.19.1 Yuhan Corp Corporate Summary
7.19.2 Yuhan Corp Business Overview
7.19.3 Yuhan Corp IBS-C Drugs Major Product Offerings
7.19.4 Yuhan Corp IBS-C Drugs Sales and Revenue in Global (2016-2021)
7.19.5 Yuhan Corp Key News
7.20 Astrazeneca Plc
7.20.1 Astrazeneca Plc Corporate Summary
7.20.2 Astrazeneca Plc Business Overview
7.20.3 Astrazeneca Plc IBS-C Drugs Major Product Offerings
7.20.4 Astrazeneca Plc IBS-C Drugs Sales and Revenue in Global (2016-2021)
7.20.5 Astrazeneca Plc Key News
7.21 The Menarini Group
7.21.1 The Menarini Group Corporate Summary
7.21.2 The Menarini Group Business Overview
7.21.3 The Menarini Group IBS-C Drugs Major Product Offerings
7.21.4 The Menarini Group IBS-C Drugs Sales and Revenue in Global (2016-2021)
7.21.5 The Menarini Group Key News
7.22 Ono Pharmaceutical Co., Ltd
7.22.1 Ono Pharmaceutical Co., Ltd Corporate Summary
7.22.2 Ono Pharmaceutical Co., Ltd Business Overview
7.22.3 Ono Pharmaceutical Co., Ltd IBS-C Drugs Major Product Offerings
7.22.4 Ono Pharmaceutical Co., Ltd IBS-C Drugs Sales and Revenue in Global (2016-2021)
7.22.5 Ono Pharmaceutical Co., Ltd Key News
8 Global IBS-C Drugs Production Capacity, Analysis
8.1 Global IBS-C Drugs Production Capacity, 2016-2027
8.2 IBS-C Drugs Production Capacity of Key Manufacturers in Global Market
8.3 Global IBS-C Drugs Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 IBS-C Drugs Supply Chain Analysis
10.1 IBS-C Drugs Industry Value Chain
10.2 IBS-C Drugs Upstream Market
10.3 IBS-C Drugs Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 IBS-C Drugs Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer

...

【免責事項】
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ 世界のIBS-C治療薬市場予測2021-2027:リナクロチド、ルビプロストン、浸透圧性下剤、覚醒剤下剤、その他(IBS-C Drugs Market - Global Outlook and Forecast 2021-2027)]についてメールでお問い合わせはこちらでお願いします。

◆H&Iグローバルリサーチのお客様(例)◆